| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 05/11/1994 | WO1994009778A1 Combinations of angiotensin-ii receptor antagonists and diuretics |
| 05/11/1994 | WO1994009772A1 Dithiocarbamates for the treatment of atherosclerosis and other cardiovascular and inflammatory diseases |
| 05/11/1994 | WO1994006919A3 Stably-transformed mammalian cells expressing a regulated, inflammatory cyclooxygenase |
| 05/11/1994 | EP0596717A1 Nutritional supplement for the elderly |
| 05/11/1994 | EP0596449A2 Serotonin receptor antagonists for treating myocardial ischemia |
| 05/11/1994 | EP0595890A1 Antimicrobial treatment methods and compositions |
| 05/11/1994 | CA2145545A1 "sensitizing hiv-1 inhibitors" sensitize hiv infected individuals to "non-nucleoside hiv treatment drugs" |
| 05/05/1994 | CA2108245A1 Method for treating myocardial ischemia employing serotonin receptor antagonists |
| 05/04/1994 | EP0595133A2 Prodrugs, their preparation and use as medicaments |
| 05/04/1994 | EP0594803A1 Method for reducing side-effects of a drug |
| 05/04/1994 | EP0594739A1 Cancer treatment |
| 05/04/1994 | EP0387314B1 Use of an agent active against retrovirus and products so produced |
| 05/04/1994 | CN1086129A Novel treatment |
| 05/03/1994 | US5308889 Medical article for surgery |
| 05/03/1994 | US5308839 Composition comprising non-steroidal anti-inflammatory agent tenidap and effectively non-antibacterial tetracycline |
| 05/03/1994 | US5308624 Ophthalmic product |
| 05/03/1994 | CA1329126C Compounds having anti-progestational and anti-estrogenic activities for induction of labor and for termination of pregnancy, as well as for the treatment of gynecological disorders |
| 05/03/1994 | CA1329119C Cytotoxic therapy |
| 04/28/1994 | WO1994009116A1 Cho cells expressing human endothelin receptors |
| 04/28/1994 | WO1994008625A1 Combination of antineoplastic agent and antisense oligonucleotides for treatment of cancer |
| 04/28/1994 | WO1994008609A1 TREATMENT OF INSULIN RESISTANCE IN OBESITY LINKED TYPE II DIABETES USING ANTAGONISTS TO TNF-α FUNCTION |
| 04/28/1994 | WO1994008602A1 Composition for irrigating intraocular tissues and maintaining mydriasis during intraocular surgery |
| 04/28/1994 | WO1994008589A1 Treatment of systemic lupus erythematosus with dehydroepiandrosterone |
| 04/28/1994 | WO1994008573A1 Use of a cell membrane permeant calcium buffer for reducing injury of mammalian cells in vivo |
| 04/28/1994 | WO1994008551A2 Pharmaceutical compositions and methods for treating cold symptoms |
| 04/28/1994 | WO1994008550A1 Anaesthetic compositions |
| 04/28/1994 | WO1994008548A1 Transfusion liquid-containing holder and prepared transfusion liquid |
| 04/28/1994 | WO1994008474A2 Medical food and method of administration |
| 04/28/1994 | WO1994005296A3 Use of cytochrome p450 inhibitors for inhibiting the metabolism of nitrogen substituted acridine |
| 04/28/1994 | CA2147663A1 Combination of antineoplastic agent and antisense oligonucleotides for treatment of cancer |
| 04/28/1994 | CA2147599A1 Container filled with infusion liquids and infusion preparation |
| 04/28/1994 | CA2147180A1 Treatment of insulin resistance in obesity linked type ii diabetes using antagonists to tnf-.alpha. function |
| 04/28/1994 | CA2126093A1 Composition for irrigating intraocular tissues and maintaining mydriasis during intraocular surgery |
| 04/27/1994 | EP0593774A1 Food composition which inhibits formation of intestinal putrefaction product |
| 04/27/1994 | EP0593658A1 Compositions and methods for inhibiting leukocyte adhesion to cns myelin |
| 04/27/1994 | EP0422097B1 Method of inhibiting the activity of human immunodeficiency virus (hiv) in vivo |
| 04/27/1994 | EP0408546B1 Improvements relating to drug delivery systems |
| 04/26/1994 | US5306503 Patch with a high content of softening ingredients |
| 04/20/1994 | EP0592557A1 Nitric oxide synthesis inhibitors for potentiating the action of pressor agents in certain hypotensive patients |
| 04/20/1994 | CN1085430A Composition for treating and inhibiting gastric and duodenal ulcers |
| 04/19/1994 | US5304570 Pharmaceutical composition useful for the treatment of cardiovascular diseases |
| 04/19/1994 | US5304559 Compositions containing a 4-quinolone derivative complexed with a divalent metal ion |
| 04/19/1994 | US5304379 A reservoir consists of tetracaine and metabolic modulator to inhibit monoamine oxidase enzyme |
| 04/19/1994 | US5304377 Blend of polylactic acid and glycolic acid copolymer |
| 04/19/1994 | US5304375 Nonoxinol-9 solubilized in polysiloxane having hydroxyl groups or polyether functionality |
| 04/19/1994 | CA1328614C Preservative system for ophthalmics formulations |
| 04/19/1994 | CA1328607C Method of improving post-ischemic myocardial dysfunction using thromboxane a_ antagonists |
| 04/14/1994 | WO1994008240A1 Drug composition to prevent desensitization of cellular receptors |
| 04/14/1994 | WO1994007505A1 Use of hyaluronic acid and forms to prevent arterial restenosis |
| 04/14/1994 | WO1994007495A1 Use of norastemizole for the treatment of allergic disorders |
| 04/14/1994 | WO1994007490A1 Method and composition for the treatment of parkinson's disease |
| 04/14/1994 | WO1994007479A2 Immunopotentiatory agents |
| 04/14/1994 | WO1994001095A3 Medicaments for the treatment of visceral pain and migraine |
| 04/14/1994 | WO1994000113A3 Medicaments containing 5-ht4 receptor antagonists |
| 04/14/1994 | WO1993024117A3 Medicaments for the treatment of anxiety |
| 04/14/1994 | CA2145521A1 Method and composition for the treatment of parkinson's disease |
| 04/13/1994 | EP0591458A1 Improved process for the long term reduction of body fat stores, insulin resistance, hyperinsulinemia and hyperglycemia in vertebrates |
| 04/13/1994 | EP0591316A1 Atp-dependent protease and use of inhibitors for same in the treatment of cachexia and muscle wasting |
| 04/13/1994 | EP0396616B1 Reduction of side effects of cancer therapy |
| 04/12/1994 | US5302604 Cholesterol lowering compounds produced by directed biosynthesis |
| 04/12/1994 | US5302399 Slow-releasing pharmaceuticals prepared with alginic acid |
| 04/12/1994 | US5302384 Administering to treat inflammation |
| 04/12/1994 | US5302172 Method and composition for iontophoresis |
| 04/12/1994 | US5301688 Method for localization and therapy of occult bladder cancer |
| 04/06/1994 | EP0590972A1 Treatment of ocular hypertension with a synergistic combination |
| 04/06/1994 | EP0590786A1 Use of certain anionic surfactants to enhance antimicrobial effectiveness of opthalmic compositions |
| 04/06/1994 | EP0590425A1 Control of fish parasites |
| 04/06/1994 | EP0451237B1 Pharmaceutical preparations |
| 04/06/1994 | EP0353295B1 Novel and improved antibodies for site specific attachment of compounds |
| 04/05/1994 | US5300294 Administering a steroid 5-a-reductase inhibiting compound |
| 03/31/1994 | WO1994006938A1 Methods for preventing multidrug resistance in cancer cells |
| 03/31/1994 | WO1994006919A2 Stably-transformed mammalian cells expressing a regulated, inflammatory cyclooxygenase |
| 03/31/1994 | WO1994006909A2 A method of preventing tumor metastasis |
| 03/31/1994 | WO1994006476A1 Method of treating tnf-dependent inflammation using tumor necrosis factor antagonists |
| 03/31/1994 | WO1994006423A1 Novel use of inhibitors of phosphodiestersase iv |
| 03/31/1994 | WO1994006399A1 Morphogen-induced periodontal tissue regeneration |
| 03/31/1994 | WO1994006280A1 Inhibitors of metazoan parasite proteases |
| 03/31/1994 | WO1994001547A3 A method for generation of antibodies to cell surface molecules |
| 03/31/1994 | CA2144856A1 A method of preventing tumor metastasis |
| 03/31/1994 | CA2144742A1 Stably-transformed mammalian cells expressing a regulated, inflammatory cyclooxygenase |
| 03/31/1994 | CA2144510A1 Novel use inhibitors of phosphodiestersase iv |
| 03/30/1994 | CN1084391A Surface modified anticancer nanoparticles |
| 03/29/1994 | US5298510 Medicaments |
| 03/29/1994 | US5298506 Use of guanylate cyclase inhibitors in the treatment of shock |
| 03/29/1994 | US5298397 Reacting liqid phase with solid phase containg antibody, separation of phases, measuring bind antibody to solid phase |
| 03/23/1994 | EP0587555A1 A bifunctional dtpa-type ligand |
| 03/22/1994 | US5296237 Water-soluble pharmaceutical metallocene-complex composition |
| 03/18/1994 | EP0573565A4 Opiate receptor antagonist modulates hyperkinetic movement disorder. |
| 03/17/1994 | WO1994005656A1 Phenylnaphthalene lactones as inhibitors of leukotriene biosynthesis |
| 03/17/1994 | WO1994005653A1 Phenylnaphthalene hydroxy acids as inhibitors of leukotriene biosynthesis |
| 03/17/1994 | WO1994005317A1 Methods for treating renin-related disorders with amylin antagonists |
| 03/17/1994 | WO1994005302A1 Dermatitis treatment compositions containing sulphur, salicylic acid and a sulphydryl group releasing agent |
| 03/17/1994 | WO1994005296A2 Use of cytochrome p450 inhibitors for inhibiting the metabolism of nitrogen substituted acridine |
| 03/17/1994 | WO1994005289A1 Method and compositions for maintaining glomerular filtration rate while inhibition extracellular matrix accumulation |
| 03/17/1994 | WO1994005203A1 Biocompatible polymers containing diagnostic or therapeutic moieties |
| 03/17/1994 | WO1994000095A3 Use of calpain inhibitors in the inhibition and treatment of medical conditions associated with increased calpain activity |
| 03/17/1994 | CA2143653A1 Methods for treating renin-related disorders with amylin antagonists |
| 03/17/1994 | CA2143221A1 Phenylnaphthalene lactones as inhibitors of leukotriene biosynthesis |
| 03/17/1994 | CA2143219A1 Phenylnaphthalene hydroxy acids as inhibitors of leukotriene biosynthesis |
| 03/17/1994 | CA2141425A1 Nitrogen substituted acridine and cytochrome p450 inhibitors and methods of use |